Littérature scientifique sur le sujet « Potassium channels, pancreatic cancer »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Potassium channels, pancreatic cancer ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Potassium channels, pancreatic cancer"
Remigante, Alessia, Paolo Zuccolini, Raffaella Barbieri, Loretta Ferrera, Rossana Morabito, Paola Gavazzo, Michael Pusch et Cristiana Picco. « NS-11021 Modulates Cancer-Associated Processes Independently of BK Channels in Melanoma and Pancreatic Duct Adenocarcinoma Cell Lines ». Cancers 13, no 23 (6 décembre 2021) : 6144. http://dx.doi.org/10.3390/cancers13236144.
Texte intégralIorio, Jessica, Lorenzo Antonuzzo, Emanuela Scarpi, Massimo D’Amico, Claudia Duranti, Luca Messerini, Clotilde Sparano et al. « Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas ». International Journal of Molecular Sciences 23, no 18 (13 septembre 2022) : 10623. http://dx.doi.org/10.3390/ijms231810623.
Texte intégralManoli, Sagar, Stefano Coppola, Claudia Duranti, Matteo Lulli, Lara Magni, Nirmala Kuppalu, Nikolaj Nielsen et al. « The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells ». Cancers 11, no 2 (23 janvier 2019) : 135. http://dx.doi.org/10.3390/cancers11020135.
Texte intégralJiang, Shuheng, Lili Zhu, Jianyu Yang, Lipeng Hu, Jianren Gu, Xin Xing, Yongwei Sun et Zhigang Zhang. « Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer ». Biochemical and Biophysical Research Communications 494, no 1-2 (décembre 2017) : 113–19. http://dx.doi.org/10.1016/j.bbrc.2017.10.072.
Texte intégralWei, Mengyan, Pu Wang, Xiufang Zhu, Masaki Morishima, Yangong Liu, Mingqi Zheng, Gang Liu et al. « Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel ». PLOS ONE 18, no 2 (2 février 2023) : e0280656. http://dx.doi.org/10.1371/journal.pone.0280656.
Texte intégralXu, Rui, Qiuyan Xu, Guanglei Huang, Xinhai Yin, Jianguo Zhu, Yikun Peng et Jukun Song. « Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma ». BioMed Research International 2019 (28 décembre 2019) : 1–11. http://dx.doi.org/10.1155/2019/9379864.
Texte intégralLi, Weiwei, Gregory C. Wilson, Magdalena Bachmann, Jiang Wang, Andrea Mattarei, Cristina Paradisi, Michael J. Edwards et al. « Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model ». Cancers 14, no 11 (25 mai 2022) : 2618. http://dx.doi.org/10.3390/cancers14112618.
Texte intégralHuang, Xi, et Lily Yeh Jan. « Targeting potassium channels in cancer ». Journal of Cell Biology 206, no 2 (21 juillet 2014) : 151–62. http://dx.doi.org/10.1083/jcb.201404136.
Texte intégralHuang, Xi, et Lily Yeh Jan. « Targeting potassium channels in cancer ». Journal of General Physiology 144, no 2 (28 juillet 2014) : 1442OIA34. http://dx.doi.org/10.1085/jgp.1442oia34.
Texte intégralHayashi, Mikio, et Ivana Novak. « Molecular basis of potassium channels in pancreatic duct epithelial cells ». Channels 7, no 6 (2 novembre 2013) : 432–41. http://dx.doi.org/10.4161/chan.26100.
Texte intégralThèses sur le sujet "Potassium channels, pancreatic cancer"
Li, Fangfang. « Regulation of pancreatic β-cell death and cancer cell migration by TPRM2 channels ». Thesis, University of Leeds, 2016. http://etheses.whiterose.ac.uk/13374/.
Texte intégralNewton, Hannah S. « Potassium channels and adenosine signaling in T cells of head and neck cancer patients ». University of Cincinnati / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1603713656776019.
Texte intégralKondratska-Klymenko, Kateryna. « Role of calcium-permeable channels in pancreatic ductal adenocarcinoma resistance to chemotherapy ». Thesis, Lille 1, 2015. http://www.theses.fr/2015LIL10099/document.
Texte intégralPancreatic ductal adenocarcinoma (PDAC) representing the most prevalent pancreatic neoplasm accounting for about 90% of all pancreatic tumors, is one of the leading causes of cancer death in men and women. The current five-year relative survival rate is about 6% . One of the reasons of this is that early stage pancreatic cancer usually has no symptoms and thus the majority of cases are diagnosed at the late metastatic or invasive stages which are not suitable for surgery. Pancreatic cancer cells have been shown to exhibit a number of genetic mutations leading to uncontrolled cell proliferation, as well as evasion of programmed cell death (apoptosis). Changes in the cytosolic free Ca2+ concentration, play a central role in many fundamental cellular processes and disturbance of the Ca2+ homeostasis regulatory mechanisms leads to a vast variety of severe pathologies, including cancer. Among these, store-operated calcium channels (SOCs) have been shown to regulate a variety of calcium dependent cellular processes altered in different cancers. However, although the role of Ca2+ and calcium-permeable channels is well established in many signaling pathways in a variety of cell types, the information of the role of calcium-permeable channels in PDAC cells is limited. Therefore, identification of the molecular nature as well as functions of calcium-permeable channels in these cells is of great importance as it can reveal novel approaches for treating pancreatic cancer through targeting calcium-dependent processes
Asher, Viren. « The expression of EAG and HERG potassium channels in ovarian cancer and their role in cell proliferation ». Thesis, University of Nottingham, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.594215.
Texte intégralInnamaa, Anni. « Expression and function of the two pore potassium (K2P) channels TREK-1, TREK-2 and TASK-3 in ovarian cancer ». Thesis, University of Nottingham, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.606812.
Texte intégralVallejo, Gracia Albert. « Kv1.3 and Kv1.5 channels in leukocytes ». Doctoral thesis, Universitat de Barcelona, 2016. http://hdl.handle.net/10803/397797.
Texte intégralAhmed, Meftun. « Oscillatory Ca2+ signaling in glucose-stimulated murine pancreatic β-cells : Modulation by amino acids, glucagon, caffeine and ryanodine ». Doctoral thesis, Uppsala universitet, Institutionen för medicinsk cellbiologi, 2001. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1408.
Texte intégralAhmed, Meftun. « Oscillatory Ca2+ signaling in glucose-stimulated murine pancreatic β-cells : Modulation by amino acids, glucagon, caffeine and ryanodine ». Doctoral thesis, Uppsala University, Department of Medical Cell Biology, 2001. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1408.
Texte intégralOscillations in cytoplasmic Ca2+ concentration ([Ca2+]i) is the key signal in glucose-stimulated β-cells governing pulsatile insulin release. The glucose response of mouse β-cells is often manifested as slow oscillations and rapid transients of [Ca2+] i. In the present study, microfluorometric technique was used to evaluate the role of amino acids, glucagon, ryanodine and caffeine on the generation and maintenance of [Ca2+] i oscillations and transients in individual murine β-cells and isolated mouse pancreatic islets. The amino acids glycine, alanine and arginine, at around their physiological concentrations, transformed the glucose-induced slow oscillations of [Ca2+] i in isolated mouse β-cells into sustained elevation. Increased Ca2+ entry promoted the reappearance of the slow [Ca2+] i oscillations. The [Ca2+] i oscillations were more resistant to amino acid transformation in intact islets, supporting the idea that cellular interactions are important for maintaining the oscillatory activity. Individual rat β-cells responded to glucose stimulation with slow [Ca2+] i oscillations due to periodic entry of Ca2+ as well as with transients evoked by mobilization of intracellular stores. The [Ca2+] i oscillations in rat β-cells had a slightly lower frequency than those in mouse β-cells and were more easily transformed into sustained elevation in the presence of glucagon or caffeine. The transients of [Ca2+] i were more common in rat than in mouse β-cells and often appeared in synchrony also in cells lacking physical contact. Depolarization enhanced the generation of [Ca2+] i transients. In accordance with the idea that β-cells have functionally active ryanodine receptors, it was found that ryanodine sometimes restored oscillatory activity abolished by caffeine. However, the IP3 receptors are the major Ca2+ release channels both in β-cells from rats and mice. Single β-cells from ob/ob mice did not differ from those of lean controls with regard to frequency, amplitudes and half-widths of the slow [Ca2+] i oscillations. Nevertheless, there was an excessive firing of [Ca2+] i transients in the β-cells from the ob/ob mice, which was suppressed by leptin at close to physiological concentrations. The enhanced firing of [Ca2+] i transients in ob/ob mouse β-cells may be due to the absence of leptin and mediated by activation of the phospholipase C signaling pathway.
Serrano, Novillo Clara. « Biology of the cardiovascular Kv7.1 functional complex ». Doctoral thesis, Universitat de Barcelona, 2020. http://hdl.handle.net/10803/668686.
Texte intégralEls canals de potassi dependents (Kv) regulen processos fisiològics molt importants, com la proliferació, la migració o el volum cel·lular. La seva rellevància es posa de manifest amb les diferents patologies associades a alteracions en la expressió dels canals, incloent malalties cardiovasculars, cerebrals, autoimmunes o càncer. Es tracta de proteïnes transmembrana formades per l’associació de 4 subunitats α que s’uneixen per formar el por. La gran varietat de diversitat funcional és deguda a la capacitat de heterotetramerització dels canals, variants d’splicing, modificacions post-traduccionals o la associació a subunitats reguladores KCNE, entre d’altres. En cardiomiòcits, Kv7.1 s’associa a KCNE1 per generar les corrents IKs, encarregades de la repolarització del potencial cardíac. La seva associació i tràfic són tema de debat des de fa anys, amb dues escoles defensant idees oposades. La primera, que les dues proteïnes s’associen en les fases inicials de la biogènesi; la segona, que trafiquen independent cap a la membrana, on difondran per trobar-se. Els Kv també s’han detectat a musculatura vascular llisa, on mantenen el potencial de repòs i controlen així el to vascular. Kv7.1, Kv7.4 i Kv7.5 es troben en diferents venes i arteries, on una expressió aberrant provoca alteracions fisiològiques. Tot i així, el seu paper concret encara es desconeix. En la present tesi doctoral hem comprovat que Kv7.1 i KCNE1 utilitzen vies diferents per arribar a la membrana plasmàtica. KCNE1 viatja per la via convencional, mentre que Kv7.1 utilitza una ruta no convencional que escapa del Golgi. Quan co-expressats, Kv7.1 redirigeix KCNE1 cap aquesta via alternativa. Hem demostrat que aquesta via són les ER-PM junctions, que també són el compartiment on la seva associació té lloc. Els interactors moleculars del canal durant el seu tràfic cap a ER-PM junctions també s’ha estudiat durant aquest treball. A més a més, hem descrit per primer cop l’expressió de Kv1.3, Kv1.5, Kv7.1 i Kv7.5 en l’endoteli de venes i artèries humanes. Hem vist un remodelatge en aquesta expressió en diferents càncers vasculars, en alguns casos relacionat amb la malignitat del tumor.
Kaizik, Stephan Martin. « Analysis of mouse models of insulin secretion disorders ». Thesis, University of Oxford, 2010. http://ora.ox.ac.uk/objects/uuid:4d44b68a-a0a0-4c92-8809-00ddbfe3e636.
Texte intégralChapitres de livres sur le sujet "Potassium channels, pancreatic cancer"
Camacho, Javier. « Ether à-go-go Potassium Channels ». Dans Encyclopedia of Cancer, 1–6. Berlin, Heidelberg : Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_2028-8.
Texte intégralCamacho, Javier. « Ether à-go-go Potassium Channels ». Dans Encyclopedia of Cancer, 1644–48. Berlin, Heidelberg : Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_2028.
Texte intégralCamacho, Javier. « Ether à-go-go Potassium Channels ». Dans Encyclopedia of Cancer, 1334–38. Berlin, Heidelberg : Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_2028.
Texte intégralYee, Nelson S., et Rosemary K. Yee. « Ion Channels as Novel Pancreatic Cancer Biomarkers and Targets ». Dans New Advances on Disease Biomarkers and Molecular Targets in Biomedicine, 75–84. Totowa, NJ : Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-456-2_5.
Texte intégralArcangeli, Annarosa. « Expression and Role of hERG Channels in Cancer Cells ». Dans The hERG Cardiac Potassium Channel : Structure, Function and Long QT Syndrome, 225–34. Chichester, UK : John Wiley & Sons, Ltd, 2008. http://dx.doi.org/10.1002/047002142x.ch17.
Texte intégralHarding, E. A., C. Kane, R. F. L. James, N. J. M. London et M. J. Dunne. « Modulation of Three Types of Potassium Selective Channels by NAD and Other Pyridine Nucleotides in Human Pancreatic β-Cells ». Dans Advances in Experimental Medicine and Biology, 43–50. Boston, MA : Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-1819-2_6.
Texte intégralGanser, Katrin, Lukas Klumpp, Helmut Bischof, Robert Lukowski, Franziska Eckert et Stephan M. Huber. « Potassium Channels in Cancer ». Dans Handbook of Experimental Pharmacology. Berlin, Heidelberg : Springer Berlin Heidelberg, 2021. http://dx.doi.org/10.1007/164_2021_465.
Texte intégral« Potassium Channels in Pancreatic P-Cells : Modulation, Pharmacology and their Role in the Regulation of Insulin Secretion ». Dans Potassium Channels And Their Modulators, 327–58. CRC Press, 1996. http://dx.doi.org/10.1201/9781482272840-20.
Texte intégralNingaraj, Nagendra S., et Divya Khaitan. « Targeting Potassium Channels for Drug Delivery to Brain Tumors ». Dans Frontiers in Anti-Cancer Drug Discovery, 231–46. BENTHAM SCIENCE PUBLISHERS, 2015. http://dx.doi.org/10.2174/9781681080581115050010.
Texte intégralYee, Nelson S. « TRPM8 Ion Channels as Potential Cancer Biomarker and Target in Pancreatic Cancer ». Dans Advances in Protein Chemistry and Structural Biology, 127–55. Elsevier, 2016. http://dx.doi.org/10.1016/bs.apcsb.2016.01.001.
Texte intégralActes de conférences sur le sujet "Potassium channels, pancreatic cancer"
Coppola, Stefano, Claudia Duranti, Annarosa Arcangeli et Thomas Schmidt. « Abstract 183 : HERG1 potassium channels perturb the β1 integrins mediated force transduction machinery in pancreatic cancer ». Dans Proceedings : AACR Annual Meeting 2018 ; April 14-18, 2018 ; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-183.
Texte intégralCoppola, S., C. Duranti, A. Arcangeli et T. Schmidt. « PO-268 The interaction of hERG1 potassium channels with integrin receptors perturbs the force transduction machinery in pancreatic cancer ». Dans Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.782.
Texte intégralBreuer, Eun-Kyoung, Clodia Osipo, Jeremiah Zartman, Claire Wells, Michael Nishimura, Walter Jones et Saverio Gentile. « Abstract B38 : Exploring targeting potassium channels in cancer : A novel strategy for therapeutic intervention ». Dans Abstracts : AACR Precision Medicine Series : Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer ; January 4-7, 2017 ; San Diego, CA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-8514.synthleth-b38.
Texte intégralIbrahim, S., A. Girault, L. Babin, M. Guéguinou, M. Potier-Cartereau, C. Vandier, G. Paintaud, T. Lecomte et W. Raoul. « PO-041 TNF pathway in metastatic colorectal cancer according to RAS status and implication of potassium channels ». Dans Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.86.
Texte intégralGupta, Bindiya, Puja Kumari, Shalini Rajaram, Rajarshi Kar, Priyanka Gogoi et Sandhya Jain. « 2022-RA-366-ESGO Calcium activated potassium channels (KCNMA1) as biomarker of pre invasive and invasive cervical cancer ». Dans ESGO 2022 Congress. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-esgo.866.
Texte intégralLo, Wing-Yee, Corinna Mohr, Friederike Steudel, Marjanka Schmidt, Douglas Easton, Reiner Hoppe, Werner Schroth, Peter Ruth, Robert Lukowski et Hiltrud Brauch. « Abstract 2030 : The role of genetic variation in calcium-activated potassium channels in breast cancer patients treated with tamoxifen ». Dans Proceedings : AACR 107th Annual Meeting 2016 ; April 16-20, 2016 ; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2030.
Texte intégralDas, Ronnie, Shubham Patle, Eric J. Seibel, Chris W. Burfeind et Saniel Lim. « Pathology in a tub step 2 : simple, rapid fabrication of curved, circular cross section millifluidic channels for biopsy preparation/3D imaging towards pancreatic cancer detection and diagnosis ». Dans Microfluidics, BioMEMS, and Medical Microsystems XVI, sous la direction de Bonnie L. Gray et Holger Becker. SPIE, 2018. http://dx.doi.org/10.1117/12.2291018.
Texte intégral